TEDOR Pharma, Inc., a full-service, contract development and manufacturing company (CDMO) founded in 2001, has closed a recapitalization and reorganization of its business, funded by investments from DORA Ventures, Inc. DORA Ventures is a newly formed investment vehicle, owned and controlled by Laura Iorio, chairwoman of TEDOR Pharma, and Doug Drysdale, president and chief executive officer of TEDOR Pharma. Ms. Iorio has served as chairwoman of TEDOR since 2009 and Mr. Drysdale previously ser...